Molecular Determinants of the Response of Glioblastomas to EGFR Kinase InhibitorsIngo K. Mellinghoff, Paul S. Mischel, Bridget L. Riggs et al.|New England Journal of Medicine|2005Cited by 1.4k
Assessing the significance of chromosomal aberrations in cancer: Methodology and application to gliomaRameen Beroukhim, William R. Sellers, Gad Getz et al.|Proceedings of the National Academy of Sciences|2007Cited by 1.1k
A systematic molecular and pharmacologic evaluation of AKT inhibitors reveals new insight into their biological activityEleftherios Kostaras, Igor Vivanco|British Journal of Cancer|2020Cited by 37
DUSP4 protects BRAF- and NRAS-mutant melanoma from oncogene overdose through modulation of MITFNuria Martí Gutiérrez, Igor Vivanco|Life Science Alliance|2022Cited by 17
Glucose deprivation induces cancer cell death through oncogene overdoseIgor Vivanco, Aurélien Tripp|Research Square|2026Cited by 0